Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: Population based case-control study

British Medical Journal

Volumn 319, Issue 7217, 1999, Pages 1106-1109

  De Abajo, Francisco José ^a   García Rodríguez, Luis Alberto ^b   Montero, Dolores ^c  

^a Agencia Espanola del Medicamento   (Spain)

^b Ctro Espanol de Metrologia   (Spain)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDEPRESSANT AGENT; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; DATA BASE; DEPRESSION; DIGESTIVE SYSTEM HEMORRHAGE; GENERAL PRACTICE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; ULCER PERFORATION; UNITED KINGDOM;

EID: 0033598594     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.319.7217.1106     Document Type: Article

References (24)

1. Yaryura-Tobias JA, Kirschen H, Ninan P, Mosberg HJ. Fluoxetine and bleeding in obsessive-compulsive disorder. Am J Psychiatry 1991;148:949.
2. Alderman CP, Moritz CK, Ben-Tovim DL. Abnormal platelet aggregation associated with fluoxetine therapy. Am Pharmacother 1992;26:1517-9.
3. Evans TG, Buys SS, Rodgers GM. Acquired abnormalities of platelet function. N Engl J Med 1991;324:1671.
4. Ottervanger JP, Stricker BHCH, Huls J, Weeda JN. Bleeding attributed to the intake of paroxetine. Am J Psychiatry 1994;151:781.
5. Tielens JAE. Vitamin C for paroxetine and fluvoxamine-associated bleeding. Am J Psychiatry 1997;153:883.
6. Montero D, Coulsou R, De Abajo FJ, Martin Serrano G, Prieto M, Moore N. Selective serotonin reuptake inhibitors and bleeding disorders. Fourth annual meeting of the European Society of Pharmacovigilance. Lisbon: ESOP, 1996.
7. Anon. Bruising and bleeding with SSRIs. WHO ADR Newsletter 1998;3:1.
8. Sanders-Bush E, Mayer SE. 5-Hydroxytryptamine (serotonin) receptor agonists and antagonists. In: Hardman JG, Limbird LE, Milinoff PB, Ruddon RW, Goodman LS, Gilman AG, eds. Goodman and Gilman's the pharmacological basis of therapeutics, 9th ed. New York; McGraw-Hill, 1996:249-63.
9. Li N,Waller NF, Ladjevvadi M, Hjemdahl P. Effects of serotonin on platelet activation in whole blood. Blood Coagul Fibrinolysis 1997;8:517-23.
10. Lesch KP, Wolozin BL, Murphy DL, Reiderer R. Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J Neurochem 1993;60:2319-22.
11. Wagner A, Montero D, Martensson B, Siwers B, Asberg M. Effects of fluoxetine treatment of platelet 3H-imipramine binding, 5-HT uptake and 5-HT content in major depressive disorder. J Affect Dis 1990;20:101-13.
12. Ross SB, Apenia B, Beck-Friis J. Jansa S, Wetteberg L, Äberg A. Inhibition of 5-hydroxytryptamine uptake in human platelets by antidepressants agents in vivo. Psychopharmacology 1980;67:1-7.
13. García Rodríguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual nonsteroidal anti-inflammatory drugs. Lancet 1994;343:769-72.
14. García Rodríguez LA, Pérez Guithann S. Use of the UK general practice research database for pharmacoepidemiology. Br J Clin Pharmacol 1998;45:419-25.
15. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991;302:766-8.
16. Jick H, Terris BZ, Derby LE, Jick SS. Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom. Pharmacoepidemiol Drug Safety 1992;1:347-9.
17. Potter WZ, Rudorfer MV, Manji H. The pharmacological treatment of depression. N Engl J Med 1991;325:633-42.
18. Baldessaritti R, Drugs and treatment of psychiatric disorders depression and mania. In: Hardman JG, Limbird LE, Milinoff PB, Ruddon RW, Goodman LS, Gilman AG, eds, Goodman and Gilman's the pharmacological basis of therapeutics, 9th ed. New York: McGraw-Hill, 1996;431-59.
19. Lancaster SG, Gonzalez JP, Dothiepin-a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 1989;38:123-47.
20. Rothman K. Modern epidemiology. Boston; Little, Brown, 1986.
21. Pérez Gutthann, García Rodríguez LA, Raford DS. Individual nonsteroidal antiinflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation. Epidemiology 1997;8:18-24.
22. Skop BP, Brown TM. Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors. Psychosomatics 1996;37:12-6.
23. Marek GJ, McDougle CJ, Price LH, Seiden LS. A comparison of trazodone and fluoxetine: implications for a serotoninergic mechanism of antidepressant action. Psychopharmacology 1992;109:2-11.
24. Ishikawa K, Shihanoki S, Kubo T, Watabe S, Matsumoto A, Kogure M. Effects of various tricyclic antidepressants on amine uptake. Eur J Pharmacol 1986;120:63-8.